Filing Details
- Accession Number:
- 0001645627-17-000072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-31 13:44:02
- Reporting Period:
- 2017-05-26
- Filing Date:
- 2017-05-31
- Accepted Time:
- 2017-05-31 13:44:02
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,001,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,002,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,003,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,004,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,005,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,006,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,007,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,008,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,009,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,010,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,011,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,012,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,013,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.06 | 21,014,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,015,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,016,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,017,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,018,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,019,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,020,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-26 | 1,000 | $0.07 | 21,021,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 1,000 | $0.07 | 21,022,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 1,000 | $0.07 | 21,023,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 1,000 | $0.07 | 21,024,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 1,000 | $0.07 | 21,025,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 1,000 | $0.07 | 21,026,249 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-30 | 1,000 | $0.06 | 21,027,249 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |